Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Cancer Discov. 2011 Jul;1(2):128–136. doi: 10.1158/2159-8290.CD-10-0044

Figure 4.

Figure 4

Effect of Raf loss on survival, MAPK activation and proliferation. (A,B) Survival is extended by homozygous loss of B-Raf (A) or C-Raf (B) in the context of K-RasG12D. (C) Reduced MAPK activation in BBK tumors at endpoint. (D) Reduced proliferation of BBK tumors at 12 weeks post Ad-Cre infection. (E, F) Evaluation of recombination of floxed Raf alleles by genotyping PCR of laser capture micro-dissected tumors.